TREPPIEDI, DONATELLA
TREPPIEDI, DONATELLA
Dipartimento di Scienze Cliniche e di Comunità
Pituitary tumors: genetic and molecular factors underlying pathogenesis and clinical behavior
2022 A. Spada, G. Mantovani, A. Lania, D. Treppiedi, F. Mangili, R. Catalano, G. Carosi, E. Sala, E. Peverelli
P720R USP8 Mutation Is Associated with a Better Responsiveness to Pasireotide in ACTH-Secreting PitNETs
2022 D. Treppiedi, G. Marra, G. DI MURO, E. Esposito, A.M. Barbieri, R. Catalano, F. Mangili, F. Bravi, M. Locatelli, A. Gerardo Lania, E. Ferrante, R. Indirli, E. Nozza, F. Arlati, A. Spada, M. Arosio, G. Mantovani, E.M. Peverelli
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells
2022 F. Mangili, E. Esposito, D. Treppiedi, R. Catalano, G. Marra, G. Di Muro, A.M. Barbieri, M. Locatelli, A.G. Lania, A. Mangone, A. Spada, M. Arosio, E. Peverelli, G. Mantovani
A novel mechanism regulating dopamine receptor type 2 (DRD2) signal transduction in pituitary tumoral cells: the role of cAMP/PKA-induced filamin A (FLNA) phosphorylation
2021 F. Mangili, D. Treppiedi, R. Catalano, G. Marra, G. DI MURO, A. Spada, M. Arosio, E.M. Peverelli, G. Mantovani
Drug resistance in pituitary tumours: from cell membrane to intracellular signalling
2021 E. Peverelli, D. Treppiedi, F. Mangili, R. Catalano, A. Spada, G. Mantovani
Genetic profiling of a cohort of Italian patients with ACTH-secreting pituitary tumors and characterization of a novel USP8 gene variant
2021 D. Treppiedi, A.M. Barbieri, G. Di Muro, G. Marra, F. Mangili, R. Catalano, E. Esposito, E. Ferrante, A.L. Serban, M. Locatelli, A.G. Lania, A. Spada, M. Arosio, E. Peverelli, G. Mantovani
The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells
2021 R. Catalano, E. Giardino, D. Treppiedi, F. Mangili, V. Morelli, F.M. Elli, A.L. Serban, M. Luconi, M. Mannelli, A. Spada, M. Arosio, G. Mantovani, E. Peverelli
β-arrestin 2 is required for dopamine receptor type 2 inhibitory effects on AKT phosphorylation and cell proliferation in pituitary tumors
2021 F. Mangili, E. Giardino, D. Treppiedi, A.M. Barbieri, R. Catalano, M. Locatelli, A.G. Lania, A. Spada, M. Arosio, G. Mantovani, E. Peverelli
Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion
2020 E. Giardino, R. Catalano, F. Mangili, A.M. Barbieri, D. Treppiedi, F.M. Elli, A. Dolci, A. Contarino, A. Spada, M. Arosio, G. Mantovani, E. Peverelli
Cytoskeleton protein Filamin A is required for efficient Somatostatin receptor type 2 internalization and recycling through Rab5 and Rab4 sorting endosomes in tumor somatotroph cells
2020 D. Treppiedi, F. Mangili, E. Giardino, R. Catalano, M. Locatelli, A. Lania, A. Spada, M. Arosio, D. Calebiro, G. Mantovani, E. Peverelli
Cytoskeleton actin-binding proteins in clinical behavior of pituitary tumors
2019 G. Mantovani, D. Treppiedi, E. Giardino, R. Catalano, F. Mangili, P. Vercesi, M. Arosio, A. Spada, E. Peverelli
Somatostatin analogs regulate tumor corticotrophs growth by reducing ERK1/2 activity.
2019 D. Treppiedi, E. Giardino, R. Catalano, F. Mangili, P. Vercesi, E. Sala, M. Locatelli, M. Arosio, A. Spada, G. Mantovani, E. Peverelli
Stem Cells in Pituitary Tumors: Experimental Evidence Supporting Their Existence and Their Role in Tumor Clinical Behavior
2019 G. Mantovani, E. Giardino, D. Treppiedi, R. Catalano, F. Mangili, A. Spada, M. Arosio, E.M. Peverelli
Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation.
2019 E. Giardino, R. Catalano, A. Barbieri, D. Treppiedi, F. Mangili, A. Spada, M. Arosio, G. Mantovani, E. Peverelli
A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment
2018 E. Peverelli, E. Giardino, D. Treppiedi, R. Catalano, F. Mangili, M. Locatelli, A.G. Lania, M. Arosio, A. Spada, G. Mantovani
cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells
2018 E. Peverelli, E. Giardino, F. Mangili, D. Treppiedi, R. Catalano, E. Ferrante, E. Sala, M. Locatelli, A.G. Lania, M. Arosio, A. Spada, G. Mantovani
Single-Molecule Microscopy Reveals Dynamic FLNA Interactions Governing SSTR2 Clustering and Internalization
2018 D. Treppiedi, M. Jobin, E. Peverelli, E. Giardino, T. Sungkaworn, U. Zabel, M. Arosio, A. Spada, G. Mantovani, D. Calebiro
HIGH-RESOLUTION SPATIOTEMPORAL ANALYSIS OF SOMATOSTATIN RECEPTOR TYPE 2 (SSTR2) - FILAMIN A (FLNA) INTERACTION BY SINGLE-MOLECULE IMAGING
2017 D. Treppiedi
Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells
2017 E. Peverelli, R. Catalano, E. Giardino, D. Treppiedi, V. Morelli, C.L. Ronchi, A. Vaczlavik, N. Fusco, S. Ferrero, J. Bertherat, F. Beuschlein, I. Chiodini, M. Arosio, A. Spada, G. Mantovani
Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors
2017 E. Peverelli, E. Giardino, D. Treppiedi, M. Meregalli, M. Belicchi, V. Vaira, S. Corbetta, C. Verdelli, E. Verrua, A.L. Serban, M. Locatelli, G. Carrabba, G. Gaudenzi, E. Malchiodi, L. Cassinelli, A.G. Lania, S. Ferrero, S. Bosari, G. Vitale, Y. Torrente, A. Spada, G. Mantovani